| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoplasmic Reticulum Stress | 14 | 2023 | 83 | 3.870 |
Why?
|
| Endoplasmic Reticulum | 15 | 2017 | 250 | 3.240 |
Why?
|
| Unfolded Protein Response | 10 | 2023 | 39 | 2.170 |
Why?
|
| Endoribonucleases | 11 | 2023 | 92 | 1.770 |
Why?
|
| Mitochondria | 10 | 2015 | 535 | 1.610 |
Why?
|
| Apoptosis | 18 | 2015 | 1683 | 1.590 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 532 | 1.080 |
Why?
|
| Pancreatic Neoplasms | 3 | 2019 | 645 | 1.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 7 | 2015 | 189 | 0.980 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2019 | 589 | 0.860 |
Why?
|
| Embryonic Stem Cells | 3 | 2015 | 78 | 0.780 |
Why?
|
| Caspase 2 | 2 | 2012 | 9 | 0.770 |
Why?
|
| Calcium | 7 | 2022 | 1156 | 0.730 |
Why?
|
| Pancreatic Elastase | 1 | 2019 | 15 | 0.710 |
Why?
|
| eIF-2 Kinase | 1 | 2019 | 46 | 0.710 |
Why?
|
| Pancreatitis | 1 | 2019 | 87 | 0.680 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 101 | 0.670 |
Why?
|
| Neuroendocrine Tumors | 1 | 2019 | 105 | 0.630 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 6 | 2010 | 12 | 0.620 |
Why?
|
| bcl-2-Associated X Protein | 6 | 2010 | 47 | 0.620 |
Why?
|
| Animals | 33 | 2023 | 26582 | 0.600 |
Why?
|
| Proteostasis Deficiencies | 1 | 2016 | 3 | 0.590 |
Why?
|
| Signal Transduction | 11 | 2019 | 3241 | 0.590 |
Why?
|
| fas Receptor | 1 | 2015 | 75 | 0.530 |
Why?
|
| Neoplasms | 3 | 2022 | 2898 | 0.530 |
Why?
|
| Mice | 23 | 2023 | 11352 | 0.530 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 1169 | 0.510 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2011 | 199 | 0.510 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 246 | 0.510 |
Why?
|
| Mutation | 8 | 2022 | 3968 | 0.460 |
Why?
|
| Motor Neurons | 2 | 2014 | 162 | 0.460 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 214 | 0.450 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2014 | 182 | 0.450 |
Why?
|
| Pancreas, Exocrine | 2 | 2023 | 18 | 0.450 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 3 | 2011 | 13 | 0.450 |
Why?
|
| Pancreatic Diseases | 2 | 2023 | 52 | 0.440 |
Why?
|
| Cysteine Endopeptidases | 1 | 2012 | 87 | 0.430 |
Why?
|
| Oncogene Protein v-crk | 1 | 2011 | 1 | 0.420 |
Why?
|
| Homeostasis | 4 | 2017 | 409 | 0.410 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2011 | 49 | 0.410 |
Why?
|
| Liver | 1 | 2017 | 1230 | 0.410 |
Why?
|
| MicroRNAs | 2 | 2014 | 534 | 0.400 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2271 | 0.380 |
Why?
|
| Islets of Langerhans | 3 | 2023 | 544 | 0.370 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1458 | 0.370 |
Why?
|
| Stress, Physiological | 1 | 2010 | 227 | 0.340 |
Why?
|
| Humans | 37 | 2023 | 86643 | 0.310 |
Why?
|
| Up-Regulation | 4 | 2019 | 712 | 0.290 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 1997 | 17 | 0.260 |
Why?
|
| Membrane Proteins | 5 | 2014 | 1196 | 0.260 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 806 | 0.260 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 2426 | 0.250 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 122 | 0.240 |
Why?
|
| CDC2 Protein Kinase | 2 | 2015 | 45 | 0.240 |
Why?
|
| Cells, Cultured | 10 | 2014 | 2818 | 0.240 |
Why?
|
| Calcium Channels | 1 | 2004 | 182 | 0.230 |
Why?
|
| Retinal Degeneration | 1 | 2023 | 28 | 0.230 |
Why?
|
| Retinitis Pigmentosa | 1 | 2023 | 35 | 0.230 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2022 | 9 | 0.220 |
Why?
|
| Calreticulin | 1 | 2022 | 13 | 0.220 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 1540 | 0.220 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 1195 | 0.220 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2022 | 4 | 0.220 |
Why?
|
| Tripartite Motif Proteins | 1 | 2022 | 3 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2022 | 7 | 0.210 |
Why?
|
| Fibroblasts | 3 | 2011 | 729 | 0.210 |
Why?
|
| HEK293 Cells | 3 | 2014 | 615 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 1997 | 302 | 0.200 |
Why?
|
| Models, Biological | 4 | 2016 | 1749 | 0.200 |
Why?
|
| Glioma | 3 | 2014 | 285 | 0.200 |
Why?
|
| Parkinson Disease | 1 | 2022 | 132 | 0.190 |
Why?
|
| Immunity, Innate | 2 | 2022 | 409 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2232 | 0.190 |
Why?
|
| Myeloproliferative Disorders | 1 | 2022 | 110 | 0.190 |
Why?
|
| Interleukin-4 | 3 | 1997 | 127 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 458 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 231 | 0.180 |
Why?
|
| Adenine | 1 | 2019 | 85 | 0.170 |
Why?
|
| Problem Behavior | 1 | 2019 | 9 | 0.170 |
Why?
|
| Phosphorylation | 6 | 2022 | 1106 | 0.170 |
Why?
|
| B-Lymphocytes | 4 | 1997 | 724 | 0.160 |
Why?
|
| Mutant Proteins | 2 | 2022 | 94 | 0.160 |
Why?
|
| Choroid Neoplasms | 1 | 2017 | 6 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2022 | 510 | 0.160 |
Why?
|
| Interleukin-2 | 3 | 1997 | 249 | 0.160 |
Why?
|
| Indoles | 1 | 2019 | 318 | 0.160 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1924 | 0.160 |
Why?
|
| Cell Survival | 1 | 2019 | 969 | 0.150 |
Why?
|
| Milk Proteins | 1 | 1996 | 24 | 0.150 |
Why?
|
| Enzyme Activation | 3 | 2014 | 692 | 0.140 |
Why?
|
| Virus Replication | 2 | 2022 | 319 | 0.140 |
Why?
|
| X-Box Binding Protein 1 | 3 | 2022 | 17 | 0.140 |
Why?
|
| Cell Line | 7 | 2015 | 2468 | 0.140 |
Why?
|
| Ribonucleases | 4 | 2022 | 92 | 0.130 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2015 | 35 | 0.130 |
Why?
|
| Cell Self Renewal | 1 | 2014 | 18 | 0.130 |
Why?
|
| RNA Stability | 2 | 2012 | 86 | 0.130 |
Why?
|
| Teratoma | 1 | 2015 | 50 | 0.130 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 29 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 70 | 0.130 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 68 | 0.130 |
Why?
|
| Transcription Factors | 4 | 2022 | 1565 | 0.120 |
Why?
|
| Immune Evasion | 1 | 2014 | 33 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2012 | 504 | 0.120 |
Why?
|
| Neuromuscular Diseases | 1 | 2014 | 30 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1197 | 0.120 |
Why?
|
| Students, Medical | 1 | 2019 | 384 | 0.120 |
Why?
|
| Endosomes | 1 | 2014 | 75 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1578 | 0.120 |
Why?
|
| Carrier Proteins | 3 | 2014 | 673 | 0.120 |
Why?
|
| Cell Line, Transformed | 2 | 2011 | 154 | 0.120 |
Why?
|
| Superoxide Dismutase | 2 | 2014 | 177 | 0.120 |
Why?
|
| Golgi Apparatus | 1 | 2014 | 117 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2014 | 379 | 0.110 |
Why?
|
| Brefeldin A | 1 | 2012 | 10 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2007 | 666 | 0.110 |
Why?
|
| Cell-Free System | 1 | 2012 | 51 | 0.110 |
Why?
|
| Regulatory Factor X Transcription Factors | 2 | 2012 | 11 | 0.110 |
Why?
|
| Thioredoxins | 1 | 2012 | 13 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2012 | 25 | 0.110 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 92 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 381 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2012 | 23 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 427 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1981 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2014 | 255 | 0.110 |
Why?
|
| Purines | 1 | 2012 | 91 | 0.110 |
Why?
|
| Cytochromes c | 1 | 2011 | 27 | 0.110 |
Why?
|
| Herpesvirus 8, Human | 1 | 2011 | 11 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2011 | 77 | 0.100 |
Why?
|
| Interferons | 2 | 2022 | 133 | 0.100 |
Why?
|
| Caspases | 1 | 2011 | 155 | 0.100 |
Why?
|
| Pancreas | 2 | 2023 | 239 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2003 | 645 | 0.100 |
Why?
|
| Furans | 1 | 2010 | 16 | 0.100 |
Why?
|
| Protein Unfolding | 1 | 2010 | 12 | 0.100 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 21 | 0.100 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2010 | 48 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 378 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 1208 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 736 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 256 | 0.090 |
Why?
|
| Proteins | 1 | 2015 | 777 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 182 | 0.090 |
Why?
|
| Autophagy | 1 | 2010 | 149 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 763 | 0.080 |
Why?
|
| Pyridines | 1 | 2010 | 310 | 0.080 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2004 | 29 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2010 | 370 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2007 | 47 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 3092 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 1 | 2007 | 139 | 0.070 |
Why?
|
| Immune System | 1 | 2007 | 93 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2003 | 129 | 0.070 |
Why?
|
| Janus Kinase 3 | 4 | 1997 | 9 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2007 | 372 | 0.070 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2004 | 17 | 0.060 |
Why?
|
| Thapsigargin | 1 | 2004 | 55 | 0.060 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 1996 | 254 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2007 | 447 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 85 | 0.060 |
Why?
|
| Trans-Activators | 2 | 1997 | 429 | 0.060 |
Why?
|
| Rhodopsin | 1 | 2023 | 19 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2004 | 498 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 425 | 0.060 |
Why?
|
| Inositol | 1 | 2022 | 15 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2014 | 271 | 0.050 |
Why?
|
| Sphingosine | 1 | 2003 | 71 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2012 | 1047 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 39 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2022 | 26 | 0.050 |
Why?
|
| Mitochondria, Liver | 1 | 2002 | 27 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 2438 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 100 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2022 | 39 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 82 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2022 | 67 | 0.050 |
Why?
|
| Microtubules | 1 | 2022 | 119 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2022 | 90 | 0.050 |
Why?
|
| Female | 3 | 2022 | 44532 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 165 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 176 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2022 | 193 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 579 | 0.050 |
Why?
|
| STAT6 Transcription Factor | 2 | 1997 | 28 | 0.050 |
Why?
|
| Janus Kinase 1 | 2 | 1996 | 15 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 1996 | 55 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2012 | 679 | 0.040 |
Why?
|
| San Francisco | 1 | 2019 | 21 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 80 | 0.040 |
Why?
|
| Feedback | 1 | 2019 | 133 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 1204 | 0.040 |
Why?
|
| Aging | 1 | 2023 | 691 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 319 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2022 | 669 | 0.040 |
Why?
|
| Receptors, IgE | 1 | 1996 | 7 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2017 | 293 | 0.040 |
Why?
|
| Retinal Detachment | 1 | 2017 | 66 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1996 | 66 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 1996 | 42 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2017 | 130 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2019 | 160 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 268 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 35 | 0.040 |
Why?
|
| Lung | 1 | 2022 | 1170 | 0.040 |
Why?
|
| Tyrosine | 1 | 1995 | 133 | 0.030 |
Why?
|
| Rats | 2 | 2014 | 3990 | 0.030 |
Why?
|
| Cyclin B2 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cyclin B1 | 1 | 2015 | 17 | 0.030 |
Why?
|
| Cyclin A | 1 | 2015 | 28 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Interleukins | 1 | 1995 | 134 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 77 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 782 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 50 | 0.030 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2014 | 23 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2014 | 68 | 0.030 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2014 | 38 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2015 | 256 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 1996 | 342 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2014 | 98 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 63 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 369 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 203 | 0.030 |
Why?
|
| Monocytes | 1 | 2014 | 214 | 0.030 |
Why?
|
| DNA Damage | 1 | 2015 | 366 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 267 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2012 | 96 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2012 | 22 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2012 | 86 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2705 | 0.030 |
Why?
|
| Retina | 1 | 2014 | 213 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 78 | 0.030 |
Why?
|
| Catalysis | 1 | 2012 | 203 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2011 | 116 | 0.030 |
Why?
|
| DNA Primers | 1 | 2012 | 543 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 273 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2012 | 142 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 262 | 0.020 |
Why?
|
| Chloroquine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2010 | 35 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 503 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2501 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 302 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 790 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 268 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 303 | 0.020 |
Why?
|
| Quinolines | 1 | 2010 | 95 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 128 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 162 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 64 | 0.020 |
Why?
|
| Cells | 1 | 2009 | 32 | 0.020 |
Why?
|
| Sirolimus | 1 | 2010 | 169 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 363 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 282 | 0.020 |
Why?
|
| Male | 4 | 2017 | 40965 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1753 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1920 | 0.020 |
Why?
|
| Insulin | 1 | 2009 | 1160 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1961 | 0.010 |
Why?
|
| Ionomycin | 1 | 2003 | 21 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 29 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2003 | 71 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2003 | 21 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 63 | 0.010 |
Why?
|
| Histamine | 1 | 2003 | 126 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 158 | 0.010 |
Why?
|
| Adenylate Kinase | 1 | 2002 | 13 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 117 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 503 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 557 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2002 | 234 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 25028 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 639 | 0.010 |
Why?
|
| Consanguinity | 1 | 1996 | 73 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1996 | 87 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 177 | 0.010 |
Why?
|
| Retroviridae | 1 | 1996 | 79 | 0.010 |
Why?
|
| X Chromosome | 1 | 1996 | 152 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 646 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1996 | 439 | 0.010 |
Why?
|
| Transfection | 1 | 1996 | 896 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 1014 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 728 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3030 | 0.010 |
Why?
|
| Child | 1 | 1996 | 6927 | 0.000 |
Why?
|